Genotoxicity of Chromium Compounds
铬化合物的遗传毒性
基本信息
- 批准号:6917117
- 负责人:
- 金额:$ 32.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-22 至 2008-06-30
- 项目状态:已结题
- 来源:
- 关键词:DNA damageDNA repairadductapoptosisascorbateautoradiographycarcinogen testingcell population studychemical carcinogenchemical carcinogenesischemical related neoplasm /cancerchromiumcysteinecysteine endopeptidasesgene induction /repressiongene targetingglutathionehistidinehuman genetic material tagmutagen testingmutagensneoplasm /cancer geneticsnucleic acid sequencep53 gene /proteinposttranslational modificationstissue /cell culturetransfection /expression vector
项目摘要
DESCRIPTION (provided by applicant): Carcinogenic activity of hexavalent chromium (Cr) compounds is firmly established by experimental and epidemiological studies. Human exposure to Cr(VI) is found in several dozen occupations and detected in populations residing in the vicinity of Cr-emitting industrial sources and Cr disposal sites. Cr(Vl) is a major air pollutant and a Superfund contaminant. The major form of DNA damage in Cr(VI)-exposed cells is abundant Cr-DNA adducts generated in the reactions of stable Cr(III) form with DNA phosphates. We have found that several Cr-DNA adducts were mutagenic during replication in human cells. Ternary DNA adducts containing bulky ligands, such as glutathione or ascorbate, induced the strongest mutagenic responses. We also determined that Cr(III)-dependent reactions were responsible for the formation of mutagenic DNA damage during reductive activation of Cr(VI) by its major biological reducers, cysteine and ascorbate. Additional data have shown that biological consequences of the formation of Cr(III)-DNA adducts are strongly influenced by the status of DNA mismatch repair system. We propose to elucidate the mechanisms of mismatch repair-dependent induction of stress signaling and formation of genetic alterations in Cr(VI)- exposed cells. Experiments will be performed to identify specific Cr-DNA adducts that are recognized by DNA mismatch repair and activate genotoxic responses. The results of this work should provide a greater understanding of molecular basis of Cr(VI) carcinogenesis, the importance of individual Cr-DNA adducts and uncover new functions of mismatch repair in recognition of DNA backbone modifications. Identification of the most potent genotoxic Cr-DNA adducts and critical pathways controlling cellular responses to Cr(VI) can be used in the development of useful biomarkers of exposure and individual susceptibility to adverse health effects.
描述(由申请方提供):六价铬(Cr)化合物的致癌活性已通过实验和流行病学研究确定。在几十种职业中发现了人类对Cr(VI)的暴露,并在居住在Cr排放工业源和Cr处置场附近的人群中检测到。Cr(VI)是一种主要的空气污染物和超级基金污染物。Cr(VI)暴露细胞中DNA损伤的主要形式是稳定的Cr(III)形式与DNA磷酸盐反应产生的丰富的Cr-DNA加合物。我们已经发现,一些Cr-DNA加合物在人体细胞复制过程中具有致突变性。三元DNA加合物含有庞大的配体,如谷胱甘肽或抗坏血酸,诱导最强的致突变反应。我们还确定,铬(III)依赖性反应是负责形成致突变DNA损伤的还原激活过程中的铬(VI)的主要生物还原剂,半胱氨酸和抗坏血酸。其他数据表明,Cr(III)-DNA加合物形成的生物学后果受到DNA错配修复系统状态的强烈影响。我们建议阐明的机制,错配修复依赖诱导应激信号和形成的遗传改变铬(VI)暴露的细胞。将进行实验以鉴定通过DNA错配修复识别并激活遗传毒性反应的特定Cr-DNA加合物。这项工作的结果应该提供一个更好的理解的分子基础的Cr(VI)致癌作用,个别Cr-DNA加合物的重要性,并发现新的功能的错配修复识别的DNA骨架修饰。鉴定最有效的遗传毒性Cr-DNA加合物和控制细胞对Cr(VI)反应的关键途径可用于开发有用的暴露生物标志物和个体对不良健康影响的易感性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anatoly Zhitkovich其他文献
Anatoly Zhitkovich的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anatoly Zhitkovich', 18)}}的其他基金
Indirect Genotoxicity in Metal Carcinogenesis
金属致癌过程中的间接遗传毒性
- 批准号:
10527323 - 财政年份:2020
- 资助金额:
$ 32.69万 - 项目类别:
Indirect Genotoxicity in Metal Carcinogenesis
金属致癌过程中的间接遗传毒性
- 批准号:
10304906 - 财政年份:2020
- 资助金额:
$ 32.69万 - 项目类别:
Regulation of p53 and Checkpoint Signaling by Chromium(VI)
Chromium(VI) 对 p53 和检查点信号传导的调节
- 批准号:
10306386 - 财政年份:2017
- 资助金额:
$ 32.69万 - 项目类别:
Regulation of p53 and Checkpoint Signaling by Chromium(VI)
Chromium(VI) 对 p53 和检查点信号传导的调节
- 批准号:
10057383 - 财政年份:2017
- 资助金额:
$ 32.69万 - 项目类别:
相似海外基金
The mutagenic consequences of replication-coupled DNA repair mechanisms
复制耦合 DNA 修复机制的致突变后果
- 批准号:
10893196 - 财政年份:2023
- 资助金额:
$ 32.69万 - 项目类别:
The mutagenic consequences of replication-coupled DNA repair mechanisms
复制耦合 DNA 修复机制的致突变后果
- 批准号:
10426485 - 财政年份:2022
- 资助金额:
$ 32.69万 - 项目类别:
Exploitation of Intrinsic DNA Repair Defects with DNA Damaging Agents in Cancer
利用 DNA 损伤剂治疗癌症中的内在 DNA 修复缺陷
- 批准号:
10441362 - 财政年份:2020
- 资助金额:
$ 32.69万 - 项目类别:
DNA Repair Phenotype the Missing Link in Breast Cancer Risk Assessment
DNA 修复表型是乳腺癌风险评估中缺失的一环
- 批准号:
10267896 - 财政年份:2020
- 资助金额:
$ 32.69万 - 项目类别:
Exploitation of Intrinsic DNA Repair Defects with DNA Damaging Agents in Cancer
利用 DNA 损伤剂治疗癌症中的内在 DNA 修复缺陷
- 批准号:
10066154 - 财政年份:2020
- 资助金额:
$ 32.69万 - 项目类别:
DNA Repair Phenotype the Missing Link in Breast Cancer Risk Assessment
DNA 修复表型是乳腺癌风险评估中缺失的一环
- 批准号:
10656666 - 财政年份:2018
- 资助金额:
$ 32.69万 - 项目类别:
DNA Repair Phenotype the Missing Link in Breast Cancer Risk Assessment
DNA 修复表型是乳腺癌风险评估中缺失的一环
- 批准号:
10215533 - 财政年份:2018
- 资助金额:
$ 32.69万 - 项目类别:
(PQ12) Enhancement of DNA repair in neurons via a targeted APE1 small molecule modifier to decrease and reverse chemotherapy-induced peripheral neuropathy (CIPN)
(PQ12) 通过靶向 APE1 小分子修饰剂增强神经元 DNA 修复,以减少和逆转化疗引起的周围神经病变 (CIPN)
- 批准号:
10241458 - 财政年份:2018
- 资助金额:
$ 32.69万 - 项目类别:
DNA Repair Phenotype the Missing Link in Breast Cancer Risk Assessment
DNA 修复表型是乳腺癌风险评估中缺失的一环
- 批准号:
10440447 - 财政年份:2018
- 资助金额:
$ 32.69万 - 项目类别:
DNA Repair Phenotype the Missing Link in Breast Cancer Risk Assessment
DNA 修复表型是乳腺癌风险评估中缺失的一环
- 批准号:
10430801 - 财政年份:2018
- 资助金额:
$ 32.69万 - 项目类别:














{{item.name}}会员




